en

PRODUCT DETAIL

Tezspire 210 mg injekčný roztok v naplnenej injekčnej striekačke

Code 2184E
MA number EU/1/22/1677/001
Product Form: sol iru 1x1,91 ml/210 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DX Other systemic drugs for obstructive airway diseases
R03DX11 Tezepelumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.09.2022
Validity: 19.09.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.10.2022
eu-flag.png sk-flag.png